Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Esophageal Neoplasms 2Resectable Pancreatic Cancer 1Rectal Neoplasms 1Pancreatic Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Gemcitabine 3folfirinox 2Cisplatin 2paricalcitol 1nimotuzumab 1Taxes 1Granulocyte-Macrophage Colony-Stimulating Factor 1Colony-Stimulating Factors 1Chemotherapy, Adjuvant 1Chemoradiotherapy, Adjuvant 1Albumin-Bound Paclitaxel 1Adjuvants, Immunologic 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Resectable Pancreatic Cancer × Chemoradiotherapy, Adjuvant × Clear all
NCT04737551 2021-02-04

Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study

Shanghai Zhongshan Hospital

Unknown
400 enrolled
Gastrointestinal

Resectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡